REFERENCES
- Reynolds D.A. A new technique for production of spherical particles. Manuf. Chemist Aer. N 1970; 41: 40–43, [CSA]
- Conine J.W., Hadley H.R. Preparation of small solid pharmaceutical spheres. Drug Cosmet. Ind 1970; 106: 38–41, [CSA]
- Newton J.M., Chapman S.R., Rowe R.C. The Influence of process variables on preparation and properties of spherical granules prepared by the process extrusion/spheronization. Int. J. Pharm 1995; 120: 101–109, [CSA], [CROSSREF]
- Hellen L., Yliruusi J., Merkku P., Kristoffersson E. Process variables of instant granulator and spheronizer: I physical properties of granules, extrudate and pellets. Int. J. Pharm 1993; 96: 197–204, [CSA], [CROSSREF]
- Hileman G.A., Goskonda S.R., Spalitto A.J., Upadrashta S.M. Response surface optimization of high dose pellets by extrusion and spheronization. Int. J. Pharm 1993; 100: 71–79, [CSA], [CROSSREF]
- Ku C.C., Joshi Y.M., Bergum J.S., Jain N.B. Bead manufacture by extrusion/spheronization—a statistical design for process optimization. Drug Dev. Ind. Pharm 1993; 19: 1505–1519, [CSA]
- Box G.E., Draper N.R. Empirical Model-Building and Response Surface. John Wiley, New York 1986
- Takayama K., Fujikawa M., Nagai T. Artificial neural network as a novel method to optimize pharmaceutical formulations. Pharm. Res 1999; 16: 1–6, [INFOTRIEVE], [CSA]
- Bourquin J., Schmidli H., van Hoogevest P., Leuenberger H. Basic concepts of artificial neural networks (ANN) in the application to pharmaceutical development. Pharm. Dev. Technol 1997; 2: 95–109, [INFOTRIEVE], [CSA]
- Sun Y., Peng Y., Chen Y., Shukla A.J. Application of artificial neural networks in the design of controlled release drug delivery systems. Adv. Drug Del. Rev 2003; 55: 1201–1215, [CSA], [CROSSREF]
- Basheer I.A., Hajmeer M. Artificial neural networks: fundamentals, computing, design, and application. J. Microbiol. Methods 2000; 43: 3–31, [INFOTRIEVE], [CSA], [CROSSREF]
- Murttoniemi E., Yliruusi J., Kinnunen P., Merkku P., Leiviska K. The advantage by the use of neural network in modeling the fluidized bed granulation process. Int. J. Pharm 1994; 108: 155–164, [CSA], [CROSSREF]
- Wu T., Pan W., Chen J., Zhang R. Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets. Drug Dev. Ind. Pharm 2000; 26(2)211–215, [INFOTRIEVE], [CSA], [CROSSREF]
- Vaithiyalingam S., Khan M.A. Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion. Int. J. Pharm 2002; 234(1–2)179–193, [INFOTRIEVE], [CSA], [CROSSREF]
- Ebube N.K., Owusu-Ababio G., Adeyeye C.M. Preformulation studies and characterization of the physicochemical properties of amorphous polymers using artificial neural networks. Int. J. Pharm 2000; 196: 27–35, [INFOTRIEVE], [CSA], [CROSSREF]
- Dowell J., Hussain A., Devane J., Young D. Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: Initial trials and experience. J. Pharm. Sci 1999; 88: 154–160, [INFOTRIEVE], [CSA], [CROSSREF]
- Opara J., Primozic S., Cvelbar P. Prediction of pharmacokinetic parameters and the assessment of their variability in bioequivalence studies by artificial neural networks. Pharm. Res 1999; 16(6)944–948, [INFOTRIEVE], [CSA], [CROSSREF]
- http://www.dissolutiontech.com/DTresour/899Art/DissProfile.html